Skin autofluorescence is associated with progression of kidney disease in type 2 diabetes: A prospective cohort study from the Hong Kong diabetes biobank.

Jin, Qiao; Lau, Eric Sh; Luk, Andrea Oy; Ozaki, Risa; Chow, Elaine Yk; So, Tammy; Yeung, Theresa; Loo, Kit-Man; Lim, Cadmon Kp; Kong, Alice Ps; So, Wing Yee; Jenkins, Alicia J; Chan, Juliana Cn; Ma, Ronald Cw

Jin, Qiao; Lau, Eric Sh; Luk, Andrea Oy; Ozaki, Risa; Chow, Elaine Yk; So, Tammy; Yeung, Theresa; Loo, Kit-Man; Lim, Cadmon Kp; Kong, Alice Ps; So, Wing Yee; Jenkins, Alicia J; Chan, Juliana Cn; Ma, Ronald Cw.

Afiliação

Jin Q; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: jinqiao@link.cuhk.edu.hk.
Lau ES; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: ericlau@link.cuhk.edu.hk.
Luk AO; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong,
Ozaki R; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong,
Chow EY; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong,
So T; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: sty020@ha.org.hk.
Yeung T; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: yhm538@ha.org.hk.
Loo KM; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: kitmanloo@yahoo.com.hk.
Lim CK; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: cadmonlim@cuhk.edu.hk.
Kong AP; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong,
So WY; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: wingyeeso@cuhk.edu.hk.
Jenkins AJ; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; NHMRC Clinical Trial Centre, Faculty of Medicine and Health, University of Sydney, Australia. Electronic address: alicia.jenkins@ctc.usyd.edu.au.
Chan JC; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong,
Ma RC; Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong, China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong,

Nutr Metab Cardiovasc Dis ; 32(2): 436-446, 2022 02.

Article em En | MEDLINE | ID: mdl-34895800

Assuntos

Diabetes Mellitus Tipo 2; Nefropatias; Bancos de Espécimes Biológicos; Diabetes Mellitus Tipo 2/complicações; Diabetes Mellitus Tipo 2/diagnóstico; Diabetes Mellitus Tipo 2/epidemiologia; Taxa de Filtração Glomerular; Produtos Finais de Glicação Avançada; Hong Kong/epidemiologia; Humanos; Estudos Prospectivos; Pele

Palavras-chave

Advanced glycation end products; Diabetic kidney disease; End-stage kidney disease; Mediation analysis; Skin autofluorescence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Nefropatias Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Nutr Metab Cardiovasc Dis Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / CIENCIAS DA NUTRICAO / METABOLISMO Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google